Showing results (241-250 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|September 29, 2021
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment optionsJiu-Wei Cui, Qing Zhou, Shun Lu, et al.
Translational Lung Cancer Research|September 29, 2021
Endovascular steerable and endobronchial precurved guiding sheaths for transbronchial needle delivery under augmented fluoroscopy and cone beam CT image guidanceQuirina M B de Ruiter, Joseph R Fontana, William F Pritchard, et al.
Translational Lung Cancer Research|September 29, 2021
Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent motion-derived parameters and apparent diffusion coefficientZheng Yuan, Xiao-Min Niu, Xue-Mei Liu, et al.
Translational Lung Cancer Research|March 14, 2022
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patientsDongsheng Yue, Weiran Liu, Chen Chen, et al.
Translational Lung Cancer Research|March 14, 2022
A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinomaYing Chen, Jinhe Xu, Lei Zhang, et al.
Translational Lung Cancer Research|March 14, 2022
Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysisJuan Jiang, Yuling Wang, Yang Gao, et al.
Translational Lung Cancer Research|March 14, 2022
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapyYuji Uehara, Taiki Hakozaki, Rui Kitadai, et al.
Translational Lung Cancer Research|March 4, 2022
Prognostic significance of procalcitonin in small cell lung cancerKosuke Ichikawa, Satoshi Watanabe, Satoru Miura, et al.
Translational Lung Cancer Research|March 4, 2022
The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinomaYucheng Hou, Weijian Song, Mingzhi Chen, et al.
Translational Lung Cancer Research|March 4, 2022
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancerZhenyang Zhang, Shuhan Xie, Weijing Cai, et al.
Pageof 240